Upload
kemunited
View
451
Download
2
Embed Size (px)
Citation preview
Adrenal Disorders - 2
Prof. Tariq Waseem
Prof. Tariq Waseem 104/15/2023
04/15/2023 Prof. Tariq Waseem 2
Mont NeboJordan
CASE SCENARIO
A 52 years old male was investigated for obesity of recent onset, polydipsia, and polyuria.
On examination, he had a B.P of 180/105mmhg and was obese, having purplish striae over the trunk and flanks.
Prof. Tariq Waseem 304/15/2023
Prof. Tariq Waseem 404/15/2023
Diagnosis?
Cushing’s Syndrome
Prof. Tariq Waseem 504/15/2023
Definition
A constellation of clinical abnormalities
due to chronic exposure to excess of
cortisol or related corticosteroid
Prof. Tariq Waseem 604/15/2023
Clinical Feature
Hypercotisolism
Lipid mobilization
Lipid catabolism
Lipid redistribution
Moon-face
buffalo hump
truncal obesity
Violaceous striae
Hepatic glucose production
Insulin resistance
Glucose intolerance
protein metabolism negative nitrogen balance
disruption of water and electrocytes metabolism
Proximal muscle weaknessDependent edema
Hypertension
Hypokalemic metabolic alkalosis
Prof. Tariq Waseem 704/15/2023
CLINICAL FEATURES OF GLUCOCORTICOID EXCESS
Frequency(%)
Weight gain 90“Moon facies” 75Hypertension 75
Violaceous striae 65Hirsutism 65Glucose intolerance 65Proximal muscle weakness 60Plethora 60Menstrual dysfunction 60Acne 40Easy bruising 40Osteopenia 40Dependent edema 40Hyperpigmentation 20Hypokalemic metabolic alkalosis 15
Prof. Tariq Waseem 804/15/2023
Prof. Tariq Waseem 904/15/2023
Prof. Tariq Waseem 1004/15/2023
FIGURE . Multiple wide striae on the abdomen of a patient with Cushing's disease.
Prof. Tariq Waseem 1104/15/2023
When stimulated by ACTH, the adrenal gland secretes cortisol and other steroid hormones. ACTH is produced by the pituitary gland and released into the petrosal venous sinuses in response to stimulation by corticotropin-releasing hormone (CRH) from the hypothalamus
Prof. Tariq Waseem 1204/15/2023
Etiology and Pathophysiology
ACTH-dependent causes
ACTH-secreting pituitary tumor ( Cushing’ s disease )
Pituitary CRH-secreting neoplasm ( ectopic CRP syndrome )
Nonpituitary ACTH-secreting neoplasm ( ectopic ACTH syndrome )
Prof. Tariq Waseem 1304/15/2023
Etiology and Pathophysiology
ACTH-independent causes Adrenal adenoma
Adrenal carcinoma
Micronodular adrenal disease
McCune-Albright syndrome
Massive macronodular adrenal diease
04/15/2023 Prof. Tariq Waseem 14
Etiology and Pathophysiology
Pseudo-cushing Syndrome
Factitious or surreptitious glucocorticoid administration
04/15/2023 Prof. Tariq Waseem 15
COMMON CAUSES OF ECTOPIC ACTH SECRETION
Small cell carcinoma of the lung 50%
Endocrine tumors of foregut origin 35%
Thymic carcinoid
Islet cell tumor
Medullary carcinoma thyroid
Bronchial carcinoid
Pheochromocytoma 5%
Ovarian tumors 2%
Prof. Tariq Waseem 1604/15/2023
Diagnosis
Clinical manifestations
Lab findings
– Plasma cortisol and rhythm (RIA)
– Urinary free cortisol
17-hydroxycortisteriod
17-ketosteriods
– Plasma ACTHProf. Tariq Waseem 1704/15/2023
Suppression tests
Screening test
– 1mg DX P.O at midnight
– Plasma cortisol (PF) at 7-8 am next day
– PF suppressed: Normal
– PF NOT suppressed: Cushing’ s Syndrome
Prof. Tariq Waseem 1804/15/2023
Suppression tests
Low dose DX suppression test
– DX 0.5 mg q6h P.O 2 days
– Urinary free cortisol decreased: Normal
– Urinary free cortisol NOT decreased:
Cushing’ s Syndrome
Prof. Tariq Waseem 1904/15/2023
Suppression tests
Large dose DX suppression testD.X 2mg q6h P.O 2 days
Urinary free cortisol reduced 50%:
Cushing’s disease (Pituitary adenoma)
Urinary free cortisol NOT reduced 50%:
Adrenal tumor,
Carcinoma,
Eectopic ACTH SyndromeProf. Tariq Waseem 2004/15/2023
ACTH Stimulation test
ACTH 25u intravenously 8h2-5 fold increase in urinary free cortisol
in Cushing’ s diseasePlasma cortisol and urinary free cortisol
increase in half of adrenal adenoma patients
No response in adrenal carcinomaProf. Tariq Waseem 2104/15/2023
CRH stimulation test Etiology diagnose (especially for pituitary ACTH-
dependent or ectopic ACTH syndrome) A newer approach is to combine a CRH stimulation test
with a dexamethasone suppression test(4mg ). method :
1 µg / kg of CRH is administered intravenously.
ACTH and cortisol levels are measured before CRH injection and 15, 30, 45, 60, 90 and 120 minutes after injection.
A rise in the cortisol value of 20 percent or more above basal level or a rise in the ACTH value of at least 50 percent above basal level is considered evidence for an ACTH-dependent lesionProf. Tariq Waseem 2204/15/2023
Metyrapone Test
Etiology diagnose (especially for pituitary or adrenal)
– Metyrapone 2-3g (30mg/kg) P.O at midnight
– Urinary 17-OHCS, Plasma ACTH,11-deoxycortisol
more above basal level : Cushing’s disease
(Pituitary adenoma)
– No response in adrenal carcinoma , tumor, ectopic
ACTH Syndrome
Prof. Tariq Waseem 2304/15/2023
Imaging diagnosis
Pituitary CT has a sensitivity of about 50% for identifying microadenomas
MRI has increased sensitivity but is not 100% predictive
Prof. Tariq Waseem 2404/15/2023
Imaging diagnosis
If diagnostic doubt need bilateral inferior petrosal sinus sampling for ACTH
04/15/2023 Prof. Tariq Waseem 25
Imaging diagnosis
04/15/2023 Prof. Tariq Waseem 26
Adrenal ultrasonography---first choiceAbdominal CT will allow identification of adrenal pathology
Imaging diagnosis
Somatostatin scintigraphy to identify sites of ectopic hormone production
04/15/2023 Prof. Tariq Waseem 27
Prof. Tariq Waseem 2804/15/2023
Etiological diagnosis Cushing’ s disease:
Adrenal adenoma:
Adrenal carcinoma:
Ectopic ACTH Syndrome:
Chronic, moderate clinical features can be suppressed by large dose test
Shorter course , mild features can NOT be suppressed by large dose test
Acute onset, progressive course, hyperandrogenic effect predominate, palpable mass, low ACTH
Appear suddenly, progress rapidly, not typical manifestation of Cushing’s syndrome, hyperpigmentation, hypokalemia, high ACTH
Prof. Tariq Waseem 2904/15/2023
Differential diagnosis Simple obesity
– General obesity, long history, over nourished– Narrow and short striae– Urinary free cortisol can be suppressed by screening ( overnight )
test and/or low-dose DX suppression test– Normal diurnal rhythm, almost normal plasma cortisol
Type 2 DM– Normal plasma cortisol and rhythm– Once blood glucose controlled, urinary free cortisol turns to normal
Alcoholic Cushingnoid Syndrome– No drinking for one week, plasma cortisol and urinary free cortisol
become normal
Depression – Lack of clinical manifestation of Cushing’s SyndromeProf. Tariq Waseem 3004/15/2023
Treatment Cushing’s disease
– Transsphenoidal microadenomectomy– Pituitary radiation– Bilateral total adrenolectomy– Drugs
Adrenal adenoma and carcinoma– Surgical removal– Drugs ( mitotane, metyrapone, ketoconazole ) for
nonresectable or metastatic carcinoma Ectopic ACTH Syndrome
– Surgical removal of the ectopic tumor– Chemotherapy, radiotherapy– Drugs ( mitotane, metyrapone, ketoconazloe )
Prof. Tariq Waseem 3104/15/2023
MANAGEMENT
CUSHING’s DISEASE :
Surgical treatment :Trans –sphenoidal surgery for elective
removal of pituitary adenoma
Prof. Tariq Waseem 3204/15/2023
CONTINUED
BILATERAL ADRENALECTOMY :If bilateral adrenalectomy is done for
pituitary adenoma dependant cushings syndrome it may lead to excessive growth of the adenoma due to lack of negative feed back provided by raised cortisol this may lead to nelson’s syndrome
Prof. Tariq Waseem 3304/15/2023
NELSON ‘s SYNDROME
Aggressive pituitary macroadenoma and very high ACTH levels causing pigmentation
Nelson ‘s syndrome can be prevented by pituitary irradiation
Prof. Tariq Waseem 3404/15/2023
ADRENAL TUMOURS
ADRENAL ADENOMA :Laproscopic removal
ADRENAL CARCINOMA :Resection and irradiation of the
carcinoma followed by cytotoxic chemotherapy
Prof. Tariq Waseem 3504/15/2023
ECTOPIC ACTH SYNDROME
Localized tumours causing this syndrome should be removed for example bronchial carcinoid
Prof. Tariq Waseem 3604/15/2023
Medical therapy of Cushing’ s Disease
Purpose
– Correct metabolic abnormalities before
attempted surgical cure
– Palliate surgically noncurable disease
– Achieve remission in patients for whom
surgery is unlikely to achieve satisfactory
long term results
Prof. Tariq Waseem 3704/15/2023
Steroidogenic inhibition– Mitotane ( OP’-DDD – Metyrapone – Aminoglutethimide – Ketoconazole
Neuromodulatory treatment– Bromocriptine – Cyproheptadin– Valproic acid – Octreotide
– Glucocorticoid receptor antagonist– RU486
Prof. Tariq Waseem 3804/15/2023
04/15/2023 Prof. Tariq Waseem 39
CASE SCENARIO No.2
A 34 years old female presented to the opd with the complains of increasing body weight over the past few months along with complains of headache over past 1 month
On examination she is found to be hypertensive ,and some black velvety discoloration was noticed around her neck and also in her armpits.
Prof. Tariq Waseem 4004/15/2023
DIAGNOSIS
?
Prof. Tariq Waseem 4104/15/2023
CASE SCENARIO No.3
A 36 years old female was referred with oligomenhorrea and hirsitism and weight gain. She has also noticed excessive hair on her face,arms and legs. She has been on Hakim medication for Asthma.
On examinaion she has excessive acne and facial hair.
Her BP is 160/100 mmhg.Prof. Tariq Waseem 4204/15/2023
Prof. Tariq Waseem 4304/15/2023
DIAGNOSIS
?
Prof. Tariq Waseem 4404/15/2023
04/15/2023 Prof. Tariq Waseem 45
Dead SeaJordan